EGRX Quote, Trading Chart, Eagle Pharmaceuticals Inc.
home / stock / egrx / egrx quote
$40.69 Last:
-0.39% Change Percent:
$40.74 Open:
$40.69 Previous Close:
$40.75 High:
$39.755 Low:
128,160 Volume:
06/11/2021 04:42:30 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
EGRX Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-11 | 40.74 | 40.69 | 40.75 | 39.755 | 128,160 |
| 2021-06-10 | 38.93 | 40.85 | 41.09 | 38.93 | 151,260 |
| 2021-06-09 | 38.235 | 38.87 | 39.15 | 37.0663 | 162,465 |
| 2021-06-08 | 38.48 | 37.59 | 38.82 | 37.11 | 85,526 |
| 2021-06-07 | 37.76 | 38.2 | 38.25 | 37.25 | 208,639 |
| 2021-06-04 | 37.5 | 37.5 | 37.88 | 37.27 | 111,816 |
| 2021-06-03 | 36.62 | 37.38 | 38.235 | 36.535 | 129,249 |
| 2021-06-02 | 38.24 | 36.86 | 38.28 | 36.48 | 154,106 |
| 2021-06-01 | 39.7 | 37.9 | 39.7 | 37.76 | 183,854 |
| 2021-05-31 | 40.67 | 39.62 | 40.775 | 39.42 | 99,001 |
| 2021-05-28 | 40.67 | 39.62 | 40.775 | 39.42 | 99,001 |
| 2021-05-27 | 41.11 | 40.52 | 41.92 | 40.37 | 65,818 |
| 2021-05-26 | 40.6 | 40.84 | 40.95 | 39.26 | 81,642 |
| 2021-05-25 | 41.76 | 40.36 | 41.76 | 40.34 | 82,053 |
| 2021-05-24 | 41.6 | 41.64 | 42.12 | 41.28 | 105,420 |
| 2021-05-21 | 41.49 | 41.66 | 41.91 | 40.89 | 96,830 |
| 2021-05-20 | 41.49 | 41.07 | 41.93 | 40.56 | 50,933 |
| 2021-05-19 | 39.92 | 41.39 | 41.55 | 39.75 | 92,100 |
| 2021-05-18 | 41.78 | 40.29 | 41.78 | 40.16 | 92,897 |
| 2021-05-17 | 41.39 | 41.77 | 41.89 | 40.3276 | 41,643 |
Eagle Pharmaceuticals Inc. Company Name:
EGRX Stock Symbol:
NASDAQ Market:
Eagle Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference 2021 as follows: ...
-
EGRX - Eagle Pharmaceuticals to Present at the 2021 RBC Capital Markets Global Healthcare Conference
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at the 2021 RBC Capital Markets Global Healthcare Conference as follow...
-
Image source: The Motley Fool. Eagle Pharmaceuticals Inc (NASDAQ: EGRX) Q1 2021 Earnings Call May 10, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Eagle Pharmaceuticals Inc (EGRX) Q1 2021 Earnings Call Transcript...